DFG Consortia

ZMB Research
DFG Consortia

Coordinated Collaborative Research Centers/Transregios (CRC/TRR)

CRC 1430: Molecular Mechanisms of Cell State Transitions

Spokesperson: Prof. Dr. Hemmo Meyer, Center of Medical Biotechnology (ZMB)

Website: https://www.uni-due.de/crc1430/

Project ZMB Member
A01: Molecular control of kinetochore microtubule interactions at the metaphase-anaphase transitionMore Prof. Dr. Stefan Westermann
A02: Bridging the gap between cell biology and biochemistry with artificial protein prosthetics in cell cycle transitionsMore Prof. Dr. Andrea Musacchio
A03: VCP/p97-cofactor complexes at the intersection of DNA repair and checkpoint controlMore Prof. Dr. Hemmo Meyer
A05: A molecular interface linking DNA replication with cell states of different replication competenceMore Prof. Dr. Dominik Boos
A06: Implications of deregulated proteostasis in cell state transitionsMore Prof. Dr. Michael Ehrmann
A07: Golgi stress: impacting cell cycle transitionsMore Prof. Dr. Doris Hellerschmied
A08: Switching of spatio-temporal Rho GTPase signal network dynamics during cell cycle phase transitionsMore Prof. Dr. Perihan Nalbant
A09: Targeting oncogene-induced DNA repair pathway switchesMore Prof. Dr. Christian Reinhardt
A11: Molecular regulation of differentiation and cell cycle in tumor-repopulating melanoma cellsMore Prof. Dr. Alexander Roesch
A13: IFNγ-induced cell state transition in melanomaMore Prof. Dr. Annette Paschen
A14: Metastatic transition in pancreatic ductal adenocarcinomaMore Dr. Barbara Grüner

CRC/TRR 296: Local Control of Thyroid Hormone Action (LOCOTACT)

Spokesperson: Prof. Dr. Dagmar Führer-Sakel, University Hospital Essen

Website: https://www.uni-due.de/crctr296/

Project ZMB Member
P08: Local TH transport and action in ischaemic brain injuryMore Prof. Dr. Dagmar Führer-Sakel
Prof. Dr. Christoph Kleinschnitz
P10: Local TH action in acute and chronic ischaemic heart diseaseMore Prof. Dr. Dagmar Führer-Sakel
Z03: Research Data Management (INF)More Prof. Dr. Dagmar Führer-Sakel

Participation in Collaborative Research Centers/Transregios (CRC/TRR)

CRC/TRR 332: Neutrophils - Origin, Fate and Function

Spokesperson: Prof. Dr. Oliver Söhnlein, WWU Münster

Website: https://www.medizin.uni-muenster.de/sfb-trr-332/startseite.html

Project ZMB Member
The role of Ly6g and CD177 as “eat me” signals to control neutrophil-mediated tissue destruction in strokeMore Prof. Dr. Matthias Gunzer
UDE Site Spokesperson

Prof. Dr. Dirk Herrmann
Deciphering molecular links between the tumour microenvironment and functional plasticity of tumour-associated neutrophilsMore Prof. Dr. Sven Brandau
Impact of type I interferons on tumour-dependent granulopoiesis and neutrophil tumourigenicityMore PD Dr. Jadwiga Jablonska-Koch
Dr. Anja Hasenberg

CRC 1439: Multilevel response to stressor increase and release in stream ecosystems (RESIST)

Spokesperson: Prof. Dr. Bernd Sures, University of Duisburg-Essen

Website: https://sfb-resist.de/

Project ZMB Member
Direct and indirect effects of multiple stressors in freshwater ecosystems on microbial parasites and scavengers (A01)More Prof. Dr. Alexander Probst
Data management and integration (Z-INF)More Prof. Dr. Alexander Probst

CRC 1399: Mechanisms of drug sensitivity and resitance in small cell lung cancer

Spokesperson: Prof. Dr. Roman Thomas, University of Cologne

Website: https://www.sfb1399.de/

Project ZMB Member
Identification and characterization of molecular vulnerabilities in SLC (A01) More Prof. Dr. Christian Reinhardt
Project ZMB Member
Harnessing molecular vulnerabilities to promote an antitumor immune microenvironment (C02) More Prof. Dr. Christian Reinhardt

CRC/TRR 247: Heterogeneous Oxidation Catalysis in the Liquid Phase – Mechanisms and Materials in Thermal, Electro-, and Photocatalysis

Spokesperson: Prof. Dr. Malte Behrens, University of Duisburg-Essen

Website: https://www.uni-due.de/sfbtrr247/

Project ZMB Member
Pulsed Laser Post Processing of Transition Metal Oxide Nanocatalysts with Defined Defect Structure (C05) More Prof. Dr. Stephan Barcikowski

CRC 1242: Non-equilibrium dynamics of condensed matter in the time domain

Spokesperson: Prof. Dr. Uwe Bovensiepen, University of Duisburg-Essen

Website: http://www.sfb1242.de/

Project ZMB Member
Photoinduced non-equilibrium dynamics in molecular adsorbates: From ensemble to single-molecule experiments (A04) More Prof. Dr. Sebastian Schlücker

Coordinated Priority Programs (SPP)

SPP 2122: Materials for Additive Manufacturing

Spokesperson: Prof. Dr. Stephan Barcikowski, University of Duisburg-Essen

Website: https://www.uni-due.de/matframe/

Project ZMB Member
Dispersion effects of nanocomposites to improve melting and resolidification behavior during SLS with CO2 and diode lasers More Prof. Dr. Stepahn Barcikowski

Participation in Priority Programs (SPP)

SPP 1926: Next Generation Optogenetics: Tool Development and Application

Spokesperson: Prof. Dr. Alexander Gottschalk, University of Frankfurt

Website: http://www.spp1926.org/

Project ZMB Member
Optogenetic manipulation of cell contraction signal network dynamics in tumors More Prof. Dr. Perihan Nalbant

SPP 1923: Innate Sensing and Restriction of Retroviruses

Spokesperson: Prof. Dr. Oliver Fackler, University Hospital Heidelberg

Website: https://spp1923.de/

Project ZMB Member
Regulation of the induction of IFNα subtypes during HIV infection More Prof. Dr. Ulf Dittmer
Dr. Kathrin Sutter

Coordinated Research Units (FOR)

FOR 2879: ImmunoStroke: From immune cells to stroke recovery

Spokesperson: Prof. Dr. Christoph Kleinschnitz, University Hospital Essen

Website: https://gepris.dfg.de/gepris/projekt/405358801

Project ZMB Member
ImmunoStroke: From Immune cells to stroke recovery Kallikrein-kinin system-mediated thrombo-inflammation as a novel target to improve long-term stroke recoveryMore Prof. Dr. Dirk M. Hermann
ImmunoStroke: From Immune Cells to Stroke Recovery Immune responses controlling post-stroke angiogenesis and microvascular integrityMore Prof. Dr. Matthias Gunzer
Prof. Dr. Dirk M. Hermann
The role of T cells in exercise-induced recovery after stroke More Prof. Dr. Wiebke Hansen

Participation in Research Units (FOR)

FOR 2816: The Autotrophy-Heterotrophy Switch in Cyanobacteria: Coherent Decision-Making at Multiple Regulatory Layers

Spokesperson: Prof. Dr. Jörg Karl Forchhammer, Eberhard Karls University Tübingen

Website: https://gepris.dfg.de/gepris/projekt/397695561

Project ZMB Member
Unraveling the cyanobacterial carbon switch and its regulation using enzyme kinetic analyses and mathematical modeling More Prof. Dr. Bettina Siebers

FOR 2407: Exploring Articular Cartilage and Subchondral Bone Degeneration and Regeneration in Osteoarthritis (ExCarBon)

Spokesperson: Prof. Dr. Susanne Grässel, University of Regensburg

Website: https://www.excarbon.com/

Project ZMB Member
Interaction of heparan sulfate and integrin signaling in maintaining the articular cartilageMore Prof. Dr. Andrea Vortkamp
Prof. Dr. Daniel Hoffmann
Prof. Dr. Perihan Nalbant

Coordinated Clinical Research Units (KFO)

KFO 337: Phenotypic Therapy and Immune Escape in Cancer (PhenoTImE)

Spokesperson: Prof. Dr. Dirk Schadendorf, University Hospital Essen

Website: https://www.uni-due.de/phenotime

Project ZMB Member
Epigenetic-metabolic (‘epi-metabolic’) reprograming as a universal survival strategy in therapy-resistant tumor cell phenotypes More Prof. Dr. Alexander Rösch
Unraveling the phenotypic coevolution of melanoma cells and neutrophils fostering metastasis and therapy resistance More Prof. Dr. Matthias Gunzer
Prof. Dr. Iris Helfrich
Translational validation of genetic and gene expression networks determining the phenotypic switch and therapy resistance of tumor cells More Prof. Dr. Dirk Schadendorf
Defining the role of CIITA in tumor cell-intrinsic and CD4+ T cell-induced phenotype switching and therapy resistance More Prof. Dr. Annette Paschen
Identification of regulators of therapy-induced epithelial mesenchymal plasticity in pancreatic cancer More Prof. Dr. Jens Siveke
Impact of the PI3K/AKT signaling pathway on epigenetic circuitry to generate immune and targeted therapy resistant melanoma phenotypes More Prof. Dr. Jürgen C. Becker